Agios Pharmaceuticals Inc. News
Agios Soars on Plan to Sell Cancer Drugs, Return $1.2B to Holders
Drugmaker Agios soared on a plan to sell an oncology portfolio to Servier for up to $2 billion and return $1.2 billion to shareholders.
Celgene, Agios Update Blood Cancer Drug Study Results in ASCO '17 Abstract
The new enasidenib data -- improved tumor response rate but shorter duration -- were made public on Wednesday night in a research abstract.
4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
Obamacare? Trumpcare? These stocks don't care.
These 4 Healthcare Charts Are Signaling Buys
Here's a rundown of four technical setups that are showing solid trading potential.
Biotechs Among 5 Stocks Setting Up for Major Breakouts
Here's how to rake in the profits off some potential big breakouts.
Is Tesla Stock a Buy or Sell After Q2 Deliveries Report? Check the Chart.
Tesla's second-quarter deliveries climbed year over year but fell from the first quarter. Here's how to trade the stock now.
Exxon Stock Slumps As Oil Slide Offsets Bets For Record Q2 Profits
"High energy prices are largely a result of underinvestment by many in the energy industry over the last several years and especially during the pandemic," Exxon said.
Ford Makes a Major Change
The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.
Stock Market Today - 7/5: Stocks Slide On Recession Fears; Dollar Hits Two-Decade Peak
A brief overnight inversion of the U.S. yield curve, as well as mounting signs of a near-term recession, have stocks on the back foot heading into the holiday-shortened week.